Cerebrospinal Fluid Management Market to reach US$ 1,840.5 Mn in 2023

csf_flowAccording to a new market report published by Transparency Market Research “Cerebrospinal Fluid (CSF) Management Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 – 2023”, the global cerebrospinal fluid (CSF) management market was valued at US$ 1,135.7 Mn in 2014 and is projected to expand at a CAGR of 5.5% from 2015 to 2023 to reach US$ 1,840.5 Mn in 2023.

Download Report Brochure For More Information: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2590

Hydrocephalus is excessive accumulation of CSF inside the head caused due to disturbance of absorption, flow, or formation. The normal CSF production rate in adults is 0.35ml/ min. It indicates that 500 ml of CSF is produced in an entire day (24 hours). In normal situations, CSF is recycled three times in a day. Hydrocephalus is caused due to various reasons such as craniofacial anomalies, benign intracranial cysts, colloid cyst, choroid plexus tumor, intracranial hemorrhage, and meningitis. However, the overall care for patients with hydrocephalus has improved in the past 10 years due to better facilities, new approaches for treatment, and growing awareness.

Based on product type, the global CSF management market has been segmented into CSF shunts and CSF drainage systems. CSF drainage system is further classified into ventricular drainage system and lumbar drainage system. The market for these segments and sub-segments has been extensively analyzed based on their utility, effectiveness, sales, and geographic presence.

Rise in incidence of neurological diseases and brain disorders, increasing geriatric population diagnosed with neurological diseases such as Alzheimer’s and Parkinson’s diseases, growing demand for minimally invasive surgeries, and increased funding by government and private organizations are likely to fuel the growth of the market in the near future. The CSF management market is projected to expand at a CAGR of 5.5% during the forecast period from 2015 to 2023. Additionally, the development of healthcare infrastructure and rise in medical expenditure by governments and increase in disposable income by the people in emerging countries such as Brazil, India, China, and other countries in Asia and Latin America is likely to drive the CSF management market in the region. However, factors such as high cost of surgery and availability of CSF shunts can restrain the market. The report offers a detailed analysis of this high growth and outlines a possible growth trajectory at global as well as regional level in terms of value for each CSF management segment.

CSF shunts was the largest product segment of the market in 2014. CSF shunts allow brain to return to a normal size by relieving the symptoms of hydrocephalus. These also ease the process of getting samples of CSF by health care providers. However, the risk associated with CSF shunts such as it leads to infection that is caused due to the patient’s own skin organism such as Staphylococcus epidermis that gains access to shunt tubing during the shunt procedure. This contamination further leads to colonization of bacteria on internal wall of valve and shunt catheter leading to bacterial colonies. This shunt infection also leads to headache, vomiting, general malaise, pyrexia, etc. This acts as a limitation and can hinder the growth of the CSF management market. A CSF drainage system clears CSF from ventricles, eliminates blood clots from intrathecal spaces, and reduces the incidence of vasospasm. CSF drainage system is found to be more accurate and cost-effective. The segment is likely to expand at the highest CAGR during the forecast period. The report has been compiled in order to update the stakeholders with the incumbent market dynamics through a graphical illustration and in-depth analysis of major sub-segments for each region considered in the study scope.

Browse Full Report With TOC: http://www.transparencymarketresearch.com/csf-management-market.html

Major players operating in the global market include DePuy Synthes (a J & J Company), Medtronic plc, B. Braun Melsungen AG, Sophysa S.A., Spiegelberg GmbH & Co. KG, Integra LifeSciences Holding Corporation, BeckerSmith Medical, Inc., and Möller Medical GmbH. The key market players are actively involved in constant innovations and developments related to technology and application to cater to the multi-dimensional needs of the end-users in order to maintain their positions in the global market.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s